Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy

MLA

Donglin Han, et al. “Sequential Co-Delivery of MiR-21 Inhibitor Followed by Burst Release Doxorubicin Using NIR-Responsive Hollow Gold Nanoparticle to Enhance Anticancer Efficacy.” Journal of Controlled Release, vol. 228, Apr. 2016, pp. 74–86. EBSCOhost, https://doi.org/10.1016/j.jconrel.2016.03.008.

APA

Donglin Han, Xubo Yuan, Chaoyong Liu, Ke Li, Ning Zhang, Hua Guo, Yu Ren, Ruirui Wang, Lizhang Gao, Qing Ye, Jianguo Tian, Xuan Zhou, Ye Tony Hu, & Duxin Sun. (2016). Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy. Journal of Controlled Release, 228, 74–86. https://doi.org/10.1016/j.jconrel.2016.03.008

Chicago

Donglin Han, Xubo Yuan, Chaoyong Liu, Ke Li, Ning Zhang, Hua Guo, Yu Ren, et al. 2016. “Sequential Co-Delivery of MiR-21 Inhibitor Followed by Burst Release Doxorubicin Using NIR-Responsive Hollow Gold Nanoparticle to Enhance Anticancer Efficacy.” Journal of Controlled Release 228 (April): 74–86. doi:10.1016/j.jconrel.2016.03.008.